Lupin Somerset is recalling Fluocinolone Acetonide Topical Solution, USP, 0.01%, due to elevated out-of-specification results for total impurities identified as oxidative degradation products. The FDA announced the recall on Jan. 15, 2019.
How to tell if you have it
- Brand: Lupin Somerset
- Product: Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle
- NDC: 43386-069-60
- Lot codes: S700214 (Exp Apr-19), S700447 (Exp Jun-19), S700787 (Exp Oct-19), S701057 (Exp Nov-19), S800107 (Exp Feb-20), S800266 (Exp Mar-20), S800524 (Exp May-20), S800791 (Exp Jul-20)
- Distribution: Nationwide in the USA and Puerto Rico
The hazard
The recall is due to failed impurities and degradation specifications, specifically elevated out-of-specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.
Context
GovInfoNow's records show Lupin Somerset has 8 other recalls on record since May 24, 2018. Other recent recalls include a March 19, 2019 labeling error for Gavilyte-N packets and a Dec. 21, 2018 subpotent drug risk for Nitrofurantoin Oral Suspension. Similar products have faced recalls, including a Dec. 30, 2025 impurity risk for Sun Pharmaceutical Fluocinolone Acetonide Solution and an Nov. 13, 2025 impurity risk for Lupin Ganirelix Acetate Injection.